[HTML][HTML] Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 …
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - Springer
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
K Torimoto, Y Okada, H Mori, M Hajime, K Tanaka… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
[HTML][HTML] Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 …
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - ncbi.nlm.nih.gov
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - europepmc.org
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes.
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health & …, 2013 - search.ebscohost.com
Background: Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
[HTML][HTML] Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 …
K Torimoto, Y Okada, H Mori… - Lipids in Health …, 2013 - lipidworld.biomedcentral.com
Statins are used to treat hypercholesterolemia in patients with type 2 diabetes mellitus, but
many of these patients fail to achieve the target LDL-C level. Recent reports have suggested …
many of these patients fail to achieve the target LDL-C level. Recent reports have suggested …
[PDF][PDF] Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 …
K Torimoto, Y Okada, H Mori, M Hajime, K Tanaka… - 2013 - researchgate.net
Background: Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - search.proquest.com
Background: Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - go.gale.com
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
K Torimoto, Y Okada, H Mori, M Hajime… - Lipids in Health and …, 2013 - infona.pl
Background Statins are used to treat hypercholesterolemia in patients with type 2 diabetes
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …
mellitus, but many of these patients fail to achieve the target LDL-C level. Recent reports …